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bstract
This study was prompted by the observation that decidual endothelial cells (DECs), unlike endothelial cells (ECs) of blood vessels in normal
kin, kidney glomeruli and brain, express surface-bound C1q in physiologic pregnancy. This finding was unexpected, because deposits of C1q are
sually observed in pathologic conditions and are associated with complement activation. In the case of DECs, we failed to detect immunoglobulins
nd C4 co-localized with C1q on the cell surface. Surprisingly, DECs expressed mRNA for the three chains of C1q and secreted detectable level
f this component in serum-free medium. The ability to synthesize C1q is acquired by DECs during pregnancy and is not shared by ECs obtained
rom endometrium and from other sources. Cell-associated C1q has a molecular weight similar to that of secreted C1q and is released from DECs
ollowing treatment with heparinase or incubation at low pH. This suggests that C1q binds to DECs and it is not constitutively expressed on the
ell surface. C1q is localized at contact sites between endovascular trophoblast and DECs and acts as an intercellular molecular bridge because
dhesion of endovascular trophoblast to DECs was inhibited by antibodies to C1q and to a receptor recognizing its globular portion expressed on
rophoblast.
2008 Elsevier Ltd. All rights reserved.
i
c
eeywords: C1q; Trophoblast; Endothelial cells; Glycosaminoglycans
. Introduction
Endothelial cells (ECs) cover the inner surface of the vessel
all and establish continuous interaction with the complementC) system that may cause their morphologic and functional
hanges (Fischetti and Tedesco, 2006).
Abbreviations: ECs, endothelial cells; DECs, decidual endothelial cells;
tMEC, uterine microvascular endothelial cells; ADMECs, human dermal
icrovascular endothelial cells; C, complement; PMN, neutrophils; CTBs,
ytotrophoblasts; vWF, von Willebrand Factor; IL, interleukin; GAGs, gly-
osaminoglycans.
∗ Corresponding author. Tel.: +39 0405584037; fax: +39 0405584023.
E-mail address: tedesco@units.it (F. Tedesco).
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oi:10.1016/j.molimm.2007.12.025C activation products are responsible for these changes and
nclude the anaphylotoxins C3a and C5a, that bind to spe-
ific receptors on ECs (Monsinjon et al., 2003; Schraufstatter
t al., 2002), and the terminal C complex that interacts with
Cs either as a sublytic membrane attached complex (Hattori
t al., 1989) or as cytolytically inactive complex (Tedesco et
l., 1997). Expression of adhesion molecules and tissue factor,
elease of chemokines, increased permeability are some of the
esponses of ECs to these factors (Bossi et al., 2004; Dobrina
t al., 2002; Kilgore et al., 1996; Selvan et al., 1998) and both
5a and SC5b-9 have been shown to promote transendothelial
igration of PMN (Dobrina et al., 2002). However, under nor-
al conditions the endothelium is protected from the stimulating
ffect of C activation products that induce a pro-inflammatory
nd pro-coagulant state by the regulatory proteins CD46, CD55
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nd CD59 expressed on their surface and the fluid phase regu-
ator Factor H that binds to ECs (Asch et al., 1986; Hamilton et
l., 1990; Jokiranta et al., 2005; McNearney et al., 1989).
ECs also represent a potential target of C1q and MBL, two
ecognition molecules of the C system that share a similar
olecular structure and are made of globular and collagen
egions (Oroszlan et al., 2007). Data collected from various
roups over the last decade have shown that immune complexes
IC)-bound C1q stimulates the expression of adhesion molecules
n EC (Lozada et al., 1995) and also that free C1q induces cell
dhesion and spreading (Feng et al., 2002) and production of IL-
, IL-6 and monocyte chemoattractant protein-1 (van den Berg
t al., 1998). The effects mediated by free C1q have been shown
o involve the interaction of C1q with C1q receptors expressed
n the surface of ECs (Peerschke et al., 1993; Peerschke et al.,
996). Under physiological conditions, approximately 10% of
1q circulates as free molecule while the majority of C1q is a
art of C1 complex together with C1r and C1s (Ziccardi and
schopp, 1982). C1q not associated with C1r and C1s is also
vailable following C activation by immune complexes which
esults in binding of C1 and release of C1r and C1s mediated by
1 inhibitor (Ziccardi and Cooper, 1979). The in vivofinding that
1q is required for deposition of immune complexes on the ves-
el wall (Stokol et al., 2004) confirms similar observations made
n vitro on human umbilical vein endothelial cells (HUVECs)
Daha et al., 1988). In the present investigation we show that
1q is present in vivo under physiologic conditions on ECs of
ecidual vessels and is used to promote cell–cell interaction.
The decidua is a newly formed tissue on the maternal side
f human placenta and is characterized by active angiogenesis
nd structural modifications of the spiral arteries in the early
hase of pregnancy. These changes, that include gradual loss of
he musculoelastic structure of the arterial wall and the replace-
ent by amorphous fibrinoid material, are essential to create
essels of low resistance that are unresponsive to vasoconstric-
ive agents (Lyall et al., 2001; Pijnenborg et al., 2006) allowing
ontinuous blood flow in the intervillous space. Failure of spi-
al artery to undergo transformation may lead to a spectrum of
regnancy failures including pre-eclampsia (Zhou et al., 1997a),
oetal growth restriction and miscarriage (Michel et al., 1990;
heppard and Bonnar, 1981).
An additional feature of the physiologic changes of spiral
rteries is the endovascular invasion of extravillous trophoblast
hat adheres to and replaces ECs giving rise to mosaic vessels in
hich trophoblast and ECs coexist (Bulla et al., 2005). We now
resent data indicating that decidual ECs (DECs) synthesize and
xpress C1q on their surface, a unique feature that is not shared
y other ECs under physiologic conditions. Furthermore, this C
omponent binds to DECs and is used as a molecular bridge to
romote trophoblast adhesion.
. Materials and methods.1. Antibodies and reagents
Two monoclonal antibodies (mAbs) anti-gC1q receptors
gC1qRs) (clones 74.5.2 and 60.11) recognizing distinct
b
w
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vology 45 (2008) 2629–2640
omains of the molecule and rabbit anti-human cC1q recep-
or (cC1qR) were previously reported (Ghebrehiwet et al.,
996). Goat antiserum to C1q, C3 and mAb to human C1q,
4c and purified C1q were purchased from Quidel (San
iego, CA). MAb85 anti-C1q was a kind gift of M. Loos
Mainz, Germany) and goat IgG anti-human C1q were pur-
hased from The Binding Site (Roma, Italy). Rabbit anti-human
1q, mAb OV-TL 12/30 anti-cytokeratin 7, mAb 6.5B5 anti-
CAM-1 and mAb F8/86 anti-von Willebrand Factor (vWF)
ere from Dako (Milano, Italy), while mAb QBEnd/10 anti-
D34 and rabbit anti-human IgG and IgM were obtained from
ovocastra–Menarini (Firenze, Italy). mAb M89D3 to CD31
as kindly provided by M.R. Zocchi (San Raffaele Hospital,
ilan, Italy) (Dobrina et al., 2002). Mouse IgG1 isotype control
as from Sigma–Aldrich (Milano, Italy) and mAb MEM-G9
nti-human leukocyte antigen G (HLA-G) was a kind gift of P.
e Bouteiller (Toulouse, France). The IgG were purified from
he antisera by affinity chromatography on protein G-Sepharose
olumn (Pharmacia, Milano, Italy). The following secondary
ntibodies were used: FITC-conjugated F(ab′)2 fragment of
oat anti-mouse Ig and FITC-labeled swine IgG anti-rabbit Ig
ere from Dako; alkaline-phosphatase (AP)-conjugated goat
gG directed to mouse IgG and rabbit IgG, and AP-conjugated
treptavidine were purchased from Sigma–Aldrich.
.2. Tissues samples
Samples of first trimester placenta were collected from
omen undergoing voluntary termination of pregnancy at 8–12
eeks’ gestation. Endometrial tissue specimens were obtained
rom fertile women undergoing hysterectomy for leiomyomato-
is in the mid proliferative and mid secretory phase defined
ccording to Noyes criteria (Noyes et al., 1975). Brain and
idney tissue samples were collected from the peri-tumoral
arenchyma of low-grade gliomas and renal cell carcinomas,
espectively. Skin samples were obtained from patients under-
oing reductive plastic surgery. The study was approved by the
nstitutional review board of The Maternal-Children’s Hospital
IRCCS “Burlo Garofolo”, Trieste, Italy) and informed consent
as obtained from all patients providing the tissue specimens.
.3. Histopathology and immunohistochemical staining
Tissue samples were fixed in 10% buffered formalin and
araffin embedded. Four-micrometers-thick sections of pla-
ental tissue were stained with hematoxylin-and-eosin and
xamined for the presence and distribution of invasive and
ndovascular trophoblast. For immunohistochemical analysis,
he slides were microwaved three times in Tris–HCl/EDTA
ethylenediamine tetraacetic acid) pH 9.0 buffer (Dako) for
min, brought to room temperature, and washed in phosphate
uffered saline (PBS). After neutralization of the endogenous
eroxidase with H2O2 for 10 min, the sections were first incu-
ated with protein block (Novocastra) for 10 min and then
ith the primary antibodies for 1 h at room temperature. The
ound antibodies were revealed using the Labeled StreptA-
idin Biotin (LSAB)+ horseradish peroxidase (HRP) kit and
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iaminobenzidine (DAB) as substrate (Dako). Triple immuno-
istochemical staining was performed according to Lan et al.
ith some modifications (Lan et al., 1995). Sections underwent
equential immunostaining with 1/100 rabbit anti-human-C1q
Dako), 1/50 mAb OV-TL 12/30 anti-human-cytokeratin 7
Dako), and 1/50 mAb QBEnd/10 anti-human-CD34 (Novo-
astra) to visualize C1q, trophoblast and endothelial cells
espectively. Anti-C1q binding was detected using the LSAB+
RP kit (Dako) and DAB as chromogen; anti-cytokeratin
was revealed by the Alkaline Phosphatase Anti-Alkaline
hosphatase (APAAP) Complex (Dako) and BCIP (5-Bromo-4-
hloro-3′-Indolyphosphate p-Toluidine Salt)/NBT (Nitro-Blue
etrazolium Chloride) as chromogen; anti-CD34 with the Per-
xidase Anti-Peroxidase (PAP) Mouse Monoclonal Complex
Dako) and AEC (-amino-9-ethyl-carbazole) as chromogen.
he sections were counterstained with hematoxylin.
Slides were evaluated under a Leica DM3000 optical micro-
cope (Leica, Germany) and images were collected using a
eica DFC320 digital camera (Leica). All the immunohisto-
hemical analysis were performed on three different tissue
amples.
.4. Cell isolation and culture
DECs were isolated from decidual biopsy specimens as
reviously described with some modifications (Bulla et al.,
005). Briefly, the tissue was finely minced, digested first with
.25% trypsin (Sigma–Aldrich) and 50g/ml DNase I (Roche,
ilano, Italy) overnight at 4 ◦C, and then with collagenase
ype 1 (3 mg/ml) (Worthington Biochemical Corporation, DBA,
ilano, Italy) for 30 min at 37 ◦C. The cells collected at the inter-
ace of Ficoll-Paque gradient (Pharmacia), after centrifugation
f the cell suspension at 690 × g for 30 min, were positively
elected with Dynabeads M-450 (Dynal, Invitrogen, Milano,
taly) coated with Ulex europaeus 1 lectin (Sigma–Aldrich).
ytofluorimetric analysis showed that more than 95% of the cells
tained for vWF (Dako). The cells were seeded in 12.5-cm2 flask
recoated with 5g/cm2 fibronectin (Roche) and maintained
n endothelial serum-free basal medium (GIBCO, Invitrogen)
upplemented with 20 ng/ml bFGF (basic Fibroblast Growth
actor) and 10 ng/ml EGF (Epidermal Growth Factor) (GIBCO,
nvitrogen).
Uterine microvascular endothelial cells (UtMECs) were puri-
ed from endometrial tissue samples by a similar procedure.
Human dermal microvascular endothelial cells (ADMECs)
ere isolated as previously described by Kraling et al. (1994)
nd seeded on 35 mm culture dishes coated with 5g/cm2
bronectin (Roche) in Medium 199 supplemented with 10%
ew Born Calf Serum (NBCS), 10% human serum, cAMP
3′–5′-cyclic adenosine monophosphate) 25g/ml, hydrocor-
isone 1g/ml, heparin 50g/ml (Sigma–Aldrich) and EGF
0 ng/ml (GIBCO, Invitrogen). ADMECs were further purified
rom a subconfluent mixed cell population with the magnetic
eads Dynabeads CD31 (Dynal, Invitrogen).
HUVECs were isolated from umbilical cord veins as previ-
usly published (Tedesco et al., 1997). All endothelial cells were
sed at their second or third passage of culture.
c
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Cytotrophoblasts (CTBs) were purified from placental tis-
ue incubated with Hanks’ Balanced Salt Solution (HBSS)
ontaining 0.25% trypsin and 0.2 mg/ml DNase I (Roche) for
0 min at 37 ◦C, following a previously published procedure
Bulla et al., 2005). The cells were seeded on 25-cm2 flask pre-
oated with 5g/cm2 fibronectin (Roche) in RPMI (GIBCO,
nvitrogen) supplemented with 10% foetal calf serum (FCS) to
emove non-adherent leucocytes and syncitiotrophoblasts, and
sed within 12 h. The cells were 95% positive for cytokeratin
and 70% positive for HLA-G by cytofluorimetric analy-
is.
.5. RNA isolation, cDNA synthesis and reverse
ranscriptase polymerase chain reaction (RT-PCR)
Cultured cells and finely minced decidual tissue were har-
ested in Omnizol (Euroclone, Milano, Italy) according to
he supplier’s instructions. Total RNA was extracted with
hloroform and precipitated with isopropanol by 12,000 × g
entrifugation at 4 ◦C. To digest contaminant genomic DNA,
NA samples were treated with 5 Units DNase RNase free
Sigma–Aldrich), re-extracted with Omnizol/chloroform and
recipitated with isopropanol. The RNA pellet was washed with
5% ethanol, resuspended in diethylpyrocarbonate-treated water
nd quantified by light absorbance at 260 nm. First strand cDNA
as synthesized from 2g total RNA using the SuperScript
I Reverse Transcriptase kit (Invitrogen) with random hex-
nucleotide primers (Roche), according to the manufacturer’s
nstructions. Polymerase chain reaction (PCR) was performed
ith Taq DNA polymerase (AccuTaq, Sigma–Aldrich), and 1l
DNA in a Techne TC-312 thermal cycler (Boneworld Scientific,
ilano, Italy). Table 1 lists the primers used for PCR follow-
ng Kaul and Loos (2001). PCR products were run through a
.5% agarose gel containing ethidium bromide for ultraviolet
etection.
.6. Enzyme-linked immunosorbent assay (ELISA)
EC-bound C1q was assessed on cells grown to conflu-
nce in 96-well tissue culture plates (Costar, Cambridge, MA).
he cells were incubated with 100l of optimal dilution of
he primary antibodies for 1 h at room temperature followed
y AP-conjugated secondary antibodies (Sigma–Aldrich). The
nzymatic reaction was developed with PNPP (p-nitrophenyl
hosphate) (Sigma–Aldrich; 1 mg/ml) as substrate and read
inetically at 405 nm using a Titertek Multiskan ELISA reader
Flow Labs, Milano, Italy).
The acid strip procedure was performed according to Heigler
t al. on DECs grown to confluence in 96-well tissue culture
lates (Costar). The cells were incubated with 100l of 0.2M
a acetate buffer containing 150 mM NaCl at pH 2.5, 3.5, or 7.5
or 10–15 s on ice and neutralized by the addition of 10l of 1 M
ris pH 9. In other experiments the cells were incubated in dPBS
ontaining 1 M KCl for 45 s at 4 ◦C. The residual cell-bound C1q
as evaluated by ELISA (see above).
C1q secreted by ECs in the supernatant was measured by
sandwich ELISA as previously described (Langeggen et al.,
2632 R. Bulla et al. / Molecular Immunology 45 (2008) 2629–2640
Table 1
Primers used for PCR analysis in accord to the method of Kaul and Loos (2001)
Sample Primers Sequence 5′ → 3′ Annealing temperature (◦C) Size of PCR product (bp) EMBL accession number
-Actin Forward CTACAATGAGCTGCGTGTGG 59 528 M 10278
Reverse AAGGAAGGCTGGAAGAGTGC
C1qA Forward ATGGTGACCGAGGACTTGTG 62 276 BC071986
Reverse GTCCTTGATGTTTCCTGGGC
C1qB Forward ACCCCAGGGATAAAAGGAGAG 60 216 BC008983
Reverse GGCAGAGAAGGCGATTTTCTG
C1qC Forward AAGGATGGGTACGACGGACTG 65 213 NM 172369
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tReverse TTTCTGCTTGTATCTGCCCTC
000) using goat IgG anti-C1q to bind C1q and the same anti-
ody labeled with biotin to reveal bound C1q followed by
P-conjugated streptavidin (Sigma–Aldrich).
.7. Flow cytometry
ECs and CTBs were detached from culture flasks with 5 mM
DTA at 37 ◦C and a total number of 5 × 105 was incubated
ith the relevant primary antibodies for 1 h at 37 ◦C followed by
ITC-conjugated goat F(ab′)2 anti-mouse Ig or swine anti rab-
it IgG (Dako). The cells were fixed with 1% paraformaldehyde
Sigma–Aldrich) and analysed for fluorescence on a FACScal-
bur instrument (BD Biosciences, Milan, Italy) using CellQuest
oftware.
.8. Preparation of cell lysate
Confluent monolayers of DECs grown in a 150 cm2 flask
ere washed with warm PBS and incubated with 1 ml sulpho-
HS-LC-biotin (sulphosuccinimidyl-6-biotinamidohexanoate,
igma) (1 mg/ml) for 20 min at room temperature. After
emoving excess biotin, the cells were lysed with pH 8
uffer containing 50 mM Tris–HCl, 250 mM NaCl, 0.5% NP-
0 (Nonidet-P40), and 1 mM PMSF (phenylmethylsulphonyl
uoride) on ice (Kaul and Loos, 2001). The cell lysate
106 cells/ml) was centrifugated (40 min, 12,000 × g, 4 ◦C) to
emove nuclei and cellular debris and the supernatant contain-
ng the labeled proteins was collected. The protein content
as estimated using the Bradford dye-binding method (Bio-
ad Labs., Richmond, CA) (Bradford, 1976) and the degree
f biotinylation assessed by dot spot assay using AP-conjugated
treptavidin.
The cell lysate was examined for the presence of gC1qR and
C1qR by a capture ELISA coating microtiter plates (Corning
ostar) with 100l of anti-gC1q-R74, anti cC1qR or non-
mmune, species-matched control IgG (10g/ml) in carbonate
uffer, pH 9.5 overnight at 4 ◦C. After washing, 100l of
iotinylated EC membranes (300g/ml) in PBS, 0.05%, Tween
0, 0.05%, skim milk were added to each well and incubated
vernight at 4 ◦C. The wells were then washed with PBS con-
aining 0.1% Tween 20 and the captured proteins were detected
sing AP-conjugated streptavidin.
a
C
(
w
n.9. Immunoafﬁnity chromatography
Anti-C1q affinity column was prepared according to the sup-
lier’s instructions by coupling goat IgG anti-C1q (Quidel) with
yanogen Bromide-Sepharose 4B (Sigma–Aldrich). Approxi-
ately 6 ml of cell-lysate or 30 ml of DEC supernatant obtained
rom 2.5 × 105 cells/ml cultured for 48 h were pre-cleared
hrough an unrelated goat IgG anti-human C5 (Quidel) column,
nd passed through a 1 ml anti-C1q column at a flow rate of
.5 ml/minute. The bound C1q was eluted with glycine buffer
H 2.7 and immediately neutralized with 1 M Tris–HCl, pH 9
t 1:10 ratio.
.10. Protein electrophoresis and immunoblotting
Affinity-purified C1q was subjected to SDS-PAGE (Sodium
odecyl Sulphate-PolyAcrylamide Gel Electrophoresis) on a
5% gel under reducing conditions according to Laemmli
1970) followed by electrophoretic transfer onto nitrocellu-
ose membrane (Hybond ECL, Amersham, Milano, Italy)
sing the semidry Semiphor transfer unit (Heifer Scientific
nstruments, San Francisco, CA). The membranes were incu-
ated with 1/1000 rabbit IgG anti-C1q (Dako) for 1 h at
7 ◦C followed by 1/20,000 AP-conjugated anti-rabbit Ig or
/4000 AP-conjugated streptavidine (Sigma–Aldrich) for 1 h
t 37 ◦C. The enzymatic reaction was developed using BCIP-
BT (Sigma–Aldrich). Rainbow RPN 756 (Amersham) was
sed as a mixture of molecular markers of known molecular
eight.
.11. Cytotrophoblasts adhesion assay
The assay to evaluate adhesion of CTBs to DECs has
een previously described (Bulla et al., 2005). Briefly, CTBs
105 cells/100l) labeled with a fluorescent dye Fast DiI
Molecular Probes, Invitrogen) were incubated with DECs in
he presence of neutralizing mAbs or control IgG for 30 min
t 37 ◦C in an air/CO2 incubator. After removing non-adherent
TBs, the number of adherent cells was counted with Infinite200
ABS 544 nm, EM 590 nm) (TECAN Italia S.r.l., Milano, Italy)
ith reference to a calibration curves established with increasing
umber of labeled CTBs.
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Fig. 1. Detection of C1q on endothelium of vessels in human decidua, endometrium, skin, brain and kidney glomeruli. Sections of paraffin-embedded maternal
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secidua (A and B), endometrium (C and D) kidney (E), skin (F), and brain (G) w
ound antibodies were revealed using the LSAB+ HRP kit and DAB as chrom
A, C, F and G) 200×; (B, D and E) 400×.
.12. Statistical analysis
Data were reported as mean ± S.D. Student’s t-test was used
o compare two groups of data.
. Results
.1. C1q is localized on DECs
There is conflicting evidence on the deposition of C compo-
ents in decidual vessels in normal and pathologic pregnancies
Hustin et al., 1983; Kitzmiller et al., 1981; Wells et al., 1987).
e have re-examined this issue looking in particular at the
resence of C components on DECs in view of the special inter-
ction of these cells with endovascular trophoblast resulting in
heir partial replacement. Immunohistochemical analysis of first
rimester placentae revealed massive deposition of C1q particu-
l
scrowaved and stained for human C1q using rabbit IgG anti-human C1q (1/100).
The sections were counterstained with hematoxylin. Original magnifications:
arly on the endothelium of spiral arteries (Fig. 1A and B) that
as not seen in the spiral arteries of endometrium (Fig. 1C and
). Furthermore, we failed to detect C1q bound to vascular ECs
n skin, kidney glomeruli and brain suggesting that under physi-
logic conditions the deposition of this C component is restricted
o DECs (Fig. 1E–G). To find out if C1q localized on the cell
urface was bound to Ig and acted as a recognition molecule for
activation through the classical pathway, we searched for IgG,
gM and C4 co-localized with C1q, but we failed to detect these
olecules on the endothelium (Fig. 2).
.2. C1q is synthesized by DECs and expressed on their
urfaceThe finding of C1q on the surface of DECs under physio-
ogic conditions in the absence of IgG, IgM and C4 led us to
uspect that cell-associated C1q was synthesized and secreted
2634 R. Bulla et al. / Molecular Immunology 45 (2008) 2629–2640
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Aig. 2. Localization of immunoglobulins and C4 on the endothelium of decid
ollowing antibodies: rabbit IgG anti-human IgM (A) or anti-human IgG (B), bo
he LSAB+ HRP kit and DAB as chromogen. The sections were counterstained
y DECs rather than deposited on the cell membrane as a
esult of C activation. To prove this, DECs were examined
or the expression of mRNA for the three chains of C1q by
T-PCR and the results were compared with those obtained
ith ECs from various sources including UtMECs, HUVECs
nd ADMECs, and also with first trimester decidual tissue.
s shown in Fig. 3A, decidua and DECs expressed mRNA
or the three chains of C1q, whereas HUVECs and ADMECs
xpressed only mRNA for the A and B chains, and UtMECs
xclusively the mRNA for the A chain. Analysis of mRNA for
–C chains of C1q in different populations of DECs showed
ome variation in the intensity of the three bands relative to
hat of -actin, and this was particularly evident for A and B
hains (Fig. 3B). Expression of mRNA for the three chains
f C1q in DECs is compatible with the synthesis of C1q
y these cells. To confirm this, we examined the cell super-
atant for the presence of C1q by ELISA and found detectable
mount of this protein that reached levels varying between 50
nd 100 ng/106 cells secreted after 48 h of culture (data not
hown).
Cytofluorimetric analysis revealed that C1q was present on
he surface of DECs. Conversely, we failed to detect C1q
n the cell membrane of HUVECs, UtMECs and ADMECs
Fig. 4A). To extend this observation, different preparations
f ECs from various sources were grown to confluence in
6 wells culture plates and analysed by ELISA for the pres-
nce of C1q on their surface. C1q was revealed in measurable
mount only on the surface of DECs, though with a large vari-
bility, while it was undetectable on HUVECs, UtMECs and
DMECs (Fig. 4B) These data were confirmed using differ-
nt monoclonal and polyclonal antibodies. Treatment of DECs
b
o
o
E
ig. 3. RT-PCR analysis of ECs for the expression of mRNA for the three chains
ncluding DECs, UtMECs, ADMECs, HUVECs) (A) or RNA samples obtained from
–C. Analysis of mRNA expression for  actin is shown for comparison.ssels. Sections of maternal decidua were microwaved and incubated with the
/100, and mAb anti-human C4c (1/100). Bound antibodies were revealed using
hematoxylin. Original magnifications: (A) 200×; (B and C) 400×.
ith 5 mM monensin or 0.5 mM brefeldin A for 24 h to block
rotein transport through the Golgi complex and secretion
otally abolished cell expression of C1q (Fig. 4C) suggest-
ng that cell-associated C1q was indeed produced by these
ells.
.3. Characterization of surface-bound C1q
The detection of substantial amount of C1q on the surface
f DECs raised the question whether C1q was an integral mem-
rane protein or was bound to ECs as a peripheral membrane
rotein. We addressed this issue by analysing the molecular
tructure of C1q immunoprecipitated from cell lysate, cell super-
atant and lysates of biotin-labeled cells by immunoblotting.
he SDS-PAGE pattern of C1q purified from cell lysate did
ot differ from that of secreted C1q and from the C1q purified
rom human plasma. In addition, the biotin-labeled C1q also
xhibited the three chains structure with a molecular weight
imilar to that of released C1q (Fig. 4D). Next, the cells grown
o confluence were incubated in medium of progressively lower
H or 1 M KCl on ice for 45 s and the residual C1q present
n the cell membrane was measured by ELISA. Incubation
f DECs in pH 2.5 medium led to partial removal of C1q
rom the cell surface, while exposure of DECs to high ionic
trength buffer was minimally, though significantly, effective
uggesting that C1q was bound to these cells via relatively
trong non-covalent interactions (data not shown). One possi-
ility that we consider was that C1q may interact with C1qRs
n the cell membrane. The presence of both these receptors
n DECs has been documented by FACS analysis and capture
LISA (Fig. 5A and B). However, we failed to detect either
of C1q. RNA prepared from first trimester decidua and freshly isolated ECs
5 different populations of DECs (B) were analysed for the expression of C1q
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Fig. 4. Analysis of ECs for surface expression and molecular characterization of C1q. (A) Cytofluorimetric analysis of C1q expression on freshly isolated ECs (DECs,
UtMECs, ADMECs, HUVECs) incubated first with mAb for C1q (10g/ml) and then with FITC-conjugated F(ab′)2 fragment of goat anti-mouse Ig (1/50). (B)
ELISA on ECs using DECs, UtMECs, ADMECs and HUVECs grown to confluence and incubated with mAb anti-human C1q (10g/ml) followed by AP-conjugated
goat IgG anti-mouse IgG (1/6000). For details see Section 2. (C) ELISA on a confluent monolayer of DECs incubated with 5M monensin, 0.5M brefeldin A
(Sigma–Aldrich) or medium alone for 24 h. The amount of C1q remaining on the cell surface was evaluated as indicated in B. *P < .01 versus untreated cells. (D)
Western blot analysis of serum purified C1q from Quidel (track 1), and of C1q affinity-purified from cell supernatant (track 2) or from cell lysate (track 3). The
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C1qR or gC1qR in the preparation of C1q affinity purified from
EC lysate both by immunoblotting and by sandwich ELISA
data not shown). Heparan sulphate (HS) was another likely
andidate that may provide binding sites for C1q on DECs in
iew of the well-known interaction of this C component with
lycosaminoglycans (GAG) (Almeda et al., 1983). To this pur-
ose, cells grown to confluence were treated with heparinase I,
I or III or the mixture of the three enzymes for 2 h at 37 ◦C
o remove cell-surface GAG. This treatment did not affect the
ntegrity of the cell monolayer. At the end of incubation, treated
nd untreated cells were examined for the presence of cell-
ound C1q. As shown in Fig. 5C, heparinase I proved to be
he most effective in removing surface C1q to level of about
5% of the untreated control. This value further increased to
pproximately 60% in the presence of the mixture of the three
eparinases. The expression of CD31 constitutively expressed
n DECs was not affected by cell treatment with heparinases
data not shown).
w
fi
t
oby AP-conjugated goat IgG anti rabbit IgG (1/20,000) (Sigma–Aldrich). C1q
-conjugated streptavidine (1/4000) (Sigma–Aldrich) (track 4). The molecular
.4. C1q is localized at the contact site between
ndovascular trophoblast and DECs and promotes
rophoblast adhesion to DECs
Having shown that C1q is localized on the surface of DECs
nd is produced by these cells under physiologic conditions, we
xamined the distribution of C1q in vessels containing endovas-
ular trophoblast. Triple staining of decidual vessels for C1q,
or cytokeratin 7 to stain trophoblast and for CD34 to recognize
Cs, revealed deposition of C1q at cell–cell contact within the
ndovascular cluster of trophoblast and at contact sites between
rophoblast and ECs (Fig. 6). The latter observation led us to
ypothesize that C1q may favour interaction of these cells. The
bility of C1q to promote trophoblast–endothelial interaction
as tested in an adhesion assay using trophoblast isolated from
rst trimester placenta and stained with a fluorescent dye prior
o addition to a confluent monolayer of DECs. The contribution
f C1q was evaluated by incubating the cells in the presence of
2636 R. Bulla et al. / Molecular Immun
Fig. 5. Expression of C1qR on DEC and effect of heparinase on cell-bound C1q.
(A) Cytofluorimetric analysis of DECs for the expression of C1q receptors. The
cells (5 × 105) were incubated with mAb 74.5.2 to gC1q-R, or rabbit anti-human
cC1q-R antibodies. The antibodies were used at the concentration of 10g/ml
to a total volume of 100l in PBS containing 1% BSA and their binding was
revealed by 1/50 FITC-conjugated goat F(ab′)2 fragments to mouse IgG or swine
IgG anti rabbit Ig. (B) Biotinylated DEC membranes were added to microtiter
plate wells coated with pAb anti cC1qR, mAb anti-gC1qR74.5.2 or species-
matched control IgG (10g/ml). The captured proteins were then detected using
AP-conjugated streptavidin and visualized by reaction with p-nitrophenyl phos-
phate. (C) Heparinase treatment of DECs. Confluent monolayer of DECs was
separately incubated with heparinase I, II or III (each at 3 × 10−2 Units/ml) or
treated with the mixture of the three enzymes for 2 h at 37 ◦C to remove cell-
surface glycosaminoglycans. Cells incubated with medium alone served as a
control. The residual cell-bound C1q was measured by ELISA. Data of C1q
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ixpression on treated cells are given as percent of C1q expressed on untreated
ells and presented as mean ± S.D. of triplicate samples from 3 independent
xperiments. *P < .01, **P < .001 versus control.
oat IgG anti-C1q, which completely prevented the adhesion of
rophoblast to DECs whereas antibodies to C3, used as a control,
ere ineffective. No inhibition was observed using antibodies toCAM-1 constitutively expressed on DECs (Bulla et al., 2005)
data not shown). These data suggest that C1q may provide a
hysical link between trophoblast and DECs (Fig. 7A). To fur-
her investigate the mechanism of cell–cell interaction, purified
(
t
t
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TBs were examined for the presence of C1q receptors on the
ell membrane by cytofluorimetric analysis and found to express
C1q-R but not cC1q-R (Fig. 7B). Based on these results, we
erformed the adhesion assay using CTBs incubated either with
Ab 60.11 to gC1q-R, that recognizes an epitope involved in
he interaction with C1q, or mAb 74.5.2 to gC1qR reacting with
n epitope not involved in the binding of C1q or with mouse iso-
ype control IgG. The cells were gently washed prior to addition
o DECs and then co-cultured for 30 min. The data presented
n Fig. 7C show that, unlike mAb 74.5.2 or the unrelated IgG,
Ab 60.11 inhibited almost completely the adhesion of CTBs to
ECs suggesting the involvement of this receptor in the binding
f C1q to CTBs.
. Discussion
C1q is a recognition molecule of the C system and its main
unction is to initiate the activation of the classical pathway
eading to the release of biologically active products that are
rimarily involved in the removal of ICs, infectious and other
armful agents. The data presented here suggest that C1q has
n additional role and contributes to the physiologic changes of
ecidual vessels that occur in placenta during the early phase of
regnancy.
The starting point for the present investigation was the obser-
ation that C1q was deposited on the endothelium of decidual
essels in the first trimester placentae. This is an unusual find-
ng in physiologic conditions, such as pregnancy, because C1q
s usually detected on cells or tissues in pathologic situations
n association with other C components. Deposition of C1q on
Cs is frequently the result of C activation triggered by antibod-
es bound to surface antigens, as we have recently shown with
ntibodies to 2-glycoprotein I that are capable of inducing C-
ependent thrombosis in a rat model (Fischetti et al., 2005). In
he case of DECs, we failed to detect immunoglobulins and C4
o-localized with C1q suggesting that C activation through the
lassical pathway is unlikely to be responsible for the binding
f C1q to ECs. This observation is in agreement with the find-
ngs that quiescent cultured ECs do not activate C (Mold and
orris, 2001) or support a very low C activation (Hindmarsh and
arks, 1998; Yin et al., 2007) and is consistent with the anti-
nflammatory property of the endothelium maintained by cell
urface and plasma C inhibitors (Fischetti and Tedesco, 2006).
The observation that deposition of C1q was restricted to
ECs and was not found on UtMECs from non-pregnant uterus
s a clear indication that binding of C1q to DECs is a pregnancy-
ssociated process. This conclusion is also supported by our
ailure to detect C1q on ECs of skin and central nervous system
icrovessels as well as on glomerular ECs. One possible expla-
ation for the different distribution of C1q on ECs from various
istricts is that C1q is constitutively expressed on the surface of
ECs. ECs are not listed among the C1q-producing cells that
nclude primarily macrophages (Bensa et al., 1983), fibroblasts
Skok et al., 1981), epithelial cells of the intestinal and urogenital
racts (Bing et al., 1975), follicular dendritic cells and interdigi-
ating cells (Schwaeble et al., 1995). The finding that HUVECs,
tMECs and ADMECs express only one or two of the mRNAs
R. Bulla et al. / Molecular Immunology 45 (2008) 2629–2640 2637
Fig. 6. Localization of C1q at the contact site between endovascular trophoblast and DECs. (A) Single staining (brown) of section of maternal decidua with rabbit IgG
anti-human-C1q (1/100) using the LSAB+ HRP kit to reveal bound antibodies and DAB as chromogen (brown); (B) double staining of the same section with rabbit
IgG anti-human-C1q as above (brown) and mAb OU-TL 12/30 to human cytokeratin 7 (1/50) developed with APAAP Complex (Dako) and NBT/BCIP as chromogen
(blue); (C) triple staining of the same section with rabbit IgG anti-human-C1q (brown), mAb OU-TL 12/30 to human cytokeratin 7 (blue) and mAb QBEnd/10
anti-human-CD34 using the PAP, Mouse Monoclonal Complex (Dako) as a revealing system and AEC as chromogen (red). The sections were counterstained with
hematoxylin. Original magnifications: (A–C) 400×.
Fig. 7. C1q mediates trophoblast–DEC interaction (A) CTBs were labeled with Fast DiI and allowed to adhere to confluent DECs for 30 min at 37 ◦C in the presence
of goat IgG to C1q and C3 (40g/ml) or medium alone. The results are given as percent of cell adhesion. (B) Cytofluorimetric analysis of CTBs purified from
first trimester placenta for the expression of C1q receptors. The cells (5 × 105) were incubated with mAb 74.5.2 or mAb 60.11, both directed to gC1q-R, or rabbit
anti-human cC1q-R antibodies. All the antibodies were used at the concentration of 10g/ml to a total volume of 100l in PBS containing 1% BSA. Binding of
the antibodies was revealed by FITC-conjugated goat F(ab′)2 fragments to mouse IgG or swine IgG anti rabbit Ig. Both antibodies were used at 1/50. (C) Percent
adhesion of labeled CTBs to confluent DECs in the presence of mAb 60.11, mAb 74.5.2 or mouse IgG1 isotype control (40g/ml). The data in A and C are presented
as mean ± S.D. of triplicate samples from at least 4 independent experiments. *P < .01, **P < .001 versus cells incubated with anti-C3 antibody (A) or mouse IgG1
(C).
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equired for the synthesis of the three chains of C1q confirmed
hat these cells are unable to produce this C component. DECs
re a notable exception because they not only express mRNAs
or A–C chains of C1q, but also synthesize C1q, which can
herefore be regarded as a marker of cell decidualization.
The presence of a substantial amount of C1q bound to DECs
s reminiscent of C1q detected on the surface of human and
uinea pig peritoneal macrophages several years ago by Loos et
l. (1981). The macrophage-associated C1q was later reported to
erive from secreted C1q and to share with the soluble molecule
he three chain structure with the only difference that the B chain
ad a molecular weight approximately 1000 Da lower (Martin et
l., 1987). Our findings indicate that DECs-bound C1q resem-
les to a large extent the molecule expressed on macrophages,
ut has some distinct features. They both contain the three chains
–C and are present on the cell membrane. However, DECs C1q
iffers from macrophage C1q for the molecular weight similar
o that of fluid phase C1q and also because it is easily released
rom the surface of DECs after short incubation in pH 2.5 buffer
Haigler et al., 1980), suggesting that its binding to the cell
urface is reversible.
Two distinct receptors recognizing either the collagen tail
Malhotra, 1993; Peerschke et al., 1993) or the globular heads
f C1q (Oroszlan et al., 2007; Peerschke et al., 1996) have
een identified on ECs. Binding of C1q to C1qRs has been
hown to induce diverse biologic effects including cell adhesion
nd spreading, expression of the adhesion molecules E-selectin,
CAM-1 and VCAM-1 (Lozada et al., 1995) and production
f IL-6, IL-8 and monocyte chemoattractant protein-1 (van den
erg et al., 1998). However, cC1qR and gC1qR are unlikely to
e involved in the binding of C1q because we failed to iden-
ify bands corresponding to either of the two C1qRs in western
lot analysis of C1q purified from DECs by affinity chromatog-
aphy and to obtain positive signals when the same preparation
as examined by a sandwich capture ELISA using antibodies to
1q and to each C1qR. This was not surprising since these recep-
ors are found predominantly inside the cell and are expressed on
esting ECs in a low number that increases upon cell exposure to
ro-inflammatory stimuli, such as LPS, TNF and IFN (Guo et
l., 1999) although this remains a controversial issue (Oroszlan
t al., 2007). In addition, C1q has been shown to bind to C1qRs
ith high affinity only when immobilized on polystyrene plate,
eat-treated or bound to ICs, suggesting that the conformational
hanges of the molecule may favour its interaction with the lig-
nd (Lozada et al., 1995; Steino et al., 2004; van den Berg et al.,
998). Heparan sulphates present on the surface of ECs offer
n alternative to C1qRs in binding C1q, as suggested by our
ata showing that treatment of DECs with heparinase removes
substantial portion of bound C1q. This is in line with previ-
usly published data providing evidence for the interaction of
1q with mucopolysaccharides including heparin sulphate and
ermatan sulphate (Almeda et al., 1983).
Immunohistochemical detection of C1q at the contact site
etween endovascular trophoblast and DECs in the absence of
activation was an unexpected finding and raised the ques-
ion whether C1q may play a role in the cross-talk between
hese two cell types. A multi-step process develops in the early
R
Aology 45 (2008) 2629–2640
hase of pregnancy that leads endovascular trophoblast to adhere
o ECs and to migrate through the inter-endothelial junctions
f spiral arteries reaching subendothelial position (Bulla et
l., 2005). As a result of trophoblast migration and localiza-
ion on the basal membrane, ECs are partially replaced and
mosaic vessel is formed resembling the vessels containing
etastatic tumor cells (Chang et al., 2000). Such a complex
rocess may require multiple cell–cell interactions that can be
rought about by interacting molecules expressed on trophoblast
nd DECs as well as by proteins spanning across the two cell
ypes. We have previously shown that VE-cadherin expressed on
ndovascular trophoblast establish homotypic interaction with
he same molecule on DECs and this in turn promotes adhe-
ion and transendothelial migration of trophoblast (Bulla et
l., 2005). VE-cadherin is expressed on invasive trophoblast
s part of a program that leads these cells to change their
attern of adhesion molecules on their way from the cell col-
mn to their vascular localization as endovascular trophoblast
Zhou et al., 1997b). We believe that C1q expressed on the
urface of DECs serves a similar purpose except that in this
ase C1q itself is able to create a molecular bridge between
VT and DECs. The critical role played by this C com-
onent in trophoblast–DEC interaction is supported by the
nding that adhesion of CTBs to DECs is inhibited by anti-
odies to C1q. Our data suggest that this is made possible
y the expression of gC1qR on CTBs that reacts with C1q
lready bound to DECs recognizing the globular heads as sug-
ested by the blocking effect seen with mAb to the globular
ortion of the molecule. The critical role played by C1q in
rophoblast–DEC interaction is also supported by the finding
hat adhesion of CTBs to DECs was inhibited by mAb 60.11,
hat recognize a C1q binding site on gC1qR, but not by mAb
4.5.2, that react with an epitope of gC1qR involved in the reac-
ion with the high molecular weight kininogen (Joseph et al.,
996).
In conclusion, we have provided data indicating that endothe-
ial cells of spiral arteries acquire the ability to synthesize C1q
uring pregnancy. The C1q binds avidly to the cell surface
nd acts as physical link between endovascular trophoblast and
ECs.
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